【结 构 式】 |
【分子编号】32037 【品名】(2S)-2-aminobutyric acid 【CA登记号】1492-24-6 |
【 分 子 式 】C4H9NO2 【 分 子 量 】103.121 【元素组成】C 46.59% H 8.8% N 13.58% O 31.03% |
合成路线1
该中间体在本合成路线中的序号:(I)The reaction of 2(S)-aminobutyric acid (I) with SOCl2 gives the acyl chloride (II), which is treated with methanol to yield the methyl ester (III). The condensation of (III) with ethyl 4-bromobutyrate (IV) by means of Na2CO3 in refluxing water affords 2(S)-[3-(ethoxycarbonyl)propylamino)butyric acid methyl ester (V), which is cyclized by means of 2-pyridinol in refluxing toluene to provide 2(S)-(2-oxopyrrolidin-1-yl)butyric acid methyl ester (VI). Finally this compound is treated with ammonia in water to furnish the target Lavetiracetam.
【1】 Cavoy, E.; Ates, C.; Surtees, J.; Burteau, A.-C.; Marmon, V. (UCB SA); Oxopyrrolidine cpds., preparation of said cpds. and their use in the manufacturing of levetiracetam and analogues. WO 0314080 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 32037 | (2S)-2-aminobutyric acid | 1492-24-6 | C4H9NO2 | 详情 | 详情 |
(II) | 61972 | (2S)-2-aminobutanoyl chloride | C4H8ClNO | 详情 | 详情 | |
(III) | 61973 | methyl (2S)-2-aminobutanoate | C5H11NO2 | 详情 | 详情 | |
(IV) | 61974 | Ethyl 4-bromobutyrate; 4-Bromobutyric acid ethyl ester; Ethyl g-Bromobutyrate; Ethyl-(4-brombutyrat); 4-Bromo-n-butyric Acid Ethyl Ester; Ethyl 4-Bromo-n-butyrate; 4-Bromobutyric acid ethylester; Ethylbromobutyrate; 4-Bromobutyric Acid, Ethyl Ester; Ethyl-4-bromobutyrate; 4-BBE | 2969-81-5 | C6H11BrO2 | 详情 | 详情 |
(V) | 61975 | methyl (2S)-2-[(4-ethoxy-4-oxobutyl)amino]butanoate | C11H21NO4 | 详情 | 详情 | |
(VI) | 61971 | methyl (2S)-2-(2-oxo-1-pyrrolidinyl)butanoate | C9H15NO3 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(II)The condensation of 2,4-difluoronitrobenzene (I) with 2(S)-aminobutyric acid (II) by means of triethylamine in refluxing acetone gives 2(S)-(5-fluoro-2-nitrophenylamino)butyric acid (III), which is reductocyclized with H2 over Raney-Ni in methanol/acetic acid, yielding 3(S)-ethyl-6-fluoro-1,2,3,4-tetrahydroquinoxalin-2-one (IV). Finally, this compound is treated with isopropyl chloroformate (V) and 4-methylpyridine in dichloromethane.
【1】 Rosner, M.; Billhardt-Troughton, U.-M.; Kirsch, R.; Kleim, J.-P.; Meichsner, C.; Riess, G.; Winkler, I. (Aventis SA); Quinoxalines, process for their preparation, and their use. CA 2160859; DE 4437406; EP 0708093; JP 1996225544; US 5723461 . |
【2】 Graul, A.; Castañer, J.; Rabasseda, X.; GW-420867X. Drugs Fut 2000, 25, 1, 24. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 32036 | 2,4-difluoro-1-nitrobenzene | 446-35-5 | C6H3F2NO2 | 详情 | 详情 |
(II) | 32037 | (2S)-2-aminobutyric acid | 1492-24-6 | C4H9NO2 | 详情 | 详情 |
(III) | 32038 | (2S)-2-(5-fluoro-2-nitroanilino)butyric acid | C10H11FN2O4 | 详情 | 详情 | |
(IV) | 32039 | (3S)-3-ethyl-6-fluoro-3,4-dihydro-2(1H)-quinoxalinone | C10H11FN2O | 详情 | 详情 | |
(V) | 26492 | 2-[(chlorocarbonyl)oxy]propane | 108-23-6 | C4H7ClO2 | 详情 | 详情 |